This hypothesis has been disproved in the case of aspirin but proved for clopidogrel using Accumetrics with a trend towards significance using TEG AUC15.
← all excerpts
Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy.
1
—
—